360 Degrees Virtual Reality-based Mirror Therapy for Stroke Patients
Launched by SAHMYOOK UNIVERSITY · Mar 21, 2023
Trial Information
Current as of July 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • who have not passed 12 months since onset;
- • who can understand and follow instructions;
- • who have ≥21 scores in Korean version of Mini-Mental State Examination (MMSE-K);
- • who have mild to moderate motor impairment according to the Fugl Meyer Assessment (FMA) scores
- Exclusion Criteria:
- • patients who have any kinds of mental disorder and/or Alzheimer's disease;
- • who have orthopedic and/or musculoskeletal injury;
- • who have apraxia; and
- • who have previous experiences of participating in investigations and/or mirror therapy.
About Sahmyook University
Sahmyook University is a distinguished academic institution based in South Korea, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in health sciences and innovative research methodologies to facilitate high-quality clinical studies. Sahmyook University aims to contribute to the development of effective therapeutic interventions and enhance patient care through rigorous clinical trials that adhere to ethical standards and regulatory guidelines. By fostering collaboration among researchers, healthcare professionals, and industry partners, the university is dedicated to translating scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Sungbae Jo, PhD candidate
Principal Investigator
Sahmyook University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials